These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
493 related articles for article (PubMed ID: 31211595)
1. Comprehensive Analysis of Core Genes and Potential Mechanisms in Rectal Cancer. Liu BX; Huang GJ; Cheng HB J Comput Biol; 2019 Nov; 26(11):1262-1277. PubMed ID: 31211595 [No Abstract] [Full Text] [Related]
2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
3. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis. Zhang H; Liu J; Fu X; Yang A Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723 [TBL] [Abstract][Full Text] [Related]
4. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis. Li F; Guo P; Dong K; Guo P; Wang H; Lv X J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342 [No Abstract] [Full Text] [Related]
5. The identification of a common different gene expression signature in patients with colorectal cancer. Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244 [TBL] [Abstract][Full Text] [Related]
6. Hub Genes and Key Pathway Identification in Colorectal Cancer Based on Bioinformatic Analysis. Lv J; Li L Biomed Res Int; 2019; 2019():1545680. PubMed ID: 31781593 [TBL] [Abstract][Full Text] [Related]
7. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Yu-Jing T; Wen-Jing T; Biao T Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534 [TBL] [Abstract][Full Text] [Related]
8. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Xu Z; Jiang P; He S Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546 [TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Yang C; Gong A Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215 [No Abstract] [Full Text] [Related]
10. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma. Zhou LN; Li SC; Li XY; Ge H; Li HM Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838 [TBL] [Abstract][Full Text] [Related]
11. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis. Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947 [TBL] [Abstract][Full Text] [Related]
12. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis. Qiu J; Sun M; Wang Y; Chen B Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995 [TBL] [Abstract][Full Text] [Related]
13. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis. Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961 [TBL] [Abstract][Full Text] [Related]
14. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer. Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036 [TBL] [Abstract][Full Text] [Related]
15. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Genetic Biomarkers and Target Genes of Peri-Implantitis Using Bioinformatics Tools. Zhang X; Wang Z; Hu L; Shen X; Liu C Biomed Res Int; 2021; 2021():1759214. PubMed ID: 34931168 [TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
18. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis. Yu C; Chen F; Jiang J; Zhang H; Zhou M Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250 [TBL] [Abstract][Full Text] [Related]
19. Expression levels of chemokine (C-X-C motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses. Lv QY; Zou HZ; Xu YY; Shao ZY; Wu RQ; Li KJ; Deng X; Gu DN; Jiang HX; Su M; Zou CL Bioengineered; 2021 Dec; 12(1):3711-3725. PubMed ID: 34269159 [TBL] [Abstract][Full Text] [Related]
20. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]